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mAbstract
Purpose: Rodent models of sepsis are frequently used to investigate pathophysiological
mechanisms and to evaluate putative therapeutic strategies. However, preclinical
efficacy in these models has failed to translate to the clinical setting. We thus questioned
the representativeness of such models and herein report a detailed comparison of
the metabolic and cardiovascular phenotypes of long-term faecal peritonitis in
fluid-resuscitated rats and mice with similar mortality profiles.
Methods: We conducted prospective laboratory-controlled studies in adult male Wistar
rats and C57 black mice. Animals were made septic by intraperitoneal injection of faecal
slurry. Rats received continuous intravenous fluid resuscitation, whereas mice received
intermittent fluid boluses subcutaneously. Sham-treated animals served as controls.
Survival was assessed over 72 h. In separate studies, whole body metabolism
(O2 consumption, CO2 production) was measured over 24 h with echocardiography
performed at early (6 h) and established (24 h) phases of sepsis. Blood gas analysis was
performed at 6 h (rats) and 24 h (rats, mice).
Results: Similar survival curves were seen in both rodent models with approximately
75% mortality at 72 h. In mice, sepsis caused severity-dependent falls in core
temperature and global metabolism. Oxygen consumption in severely septic mice fell
by 38% within 2 h, and 80% at 22 h compared with baseline values. This was
only partially restored by external warming. By contrast, septic rats maintained core
temperature; only severely affected animals showed a pre-mortem decline in oxygen
consumption. Significant myocardial dysfunction was seen in mice during early and
established sepsis, whereas peak velocity and other hemodynamic variables in rats were
similar at 6 h and significantly worse by 24 h in severely septic animals only.
Conclusions: Markedly differing metabolic and cardiovascular profiles were seen in
long-term fluid-resuscitated rat and mouse models of bacterial sepsis despite similar
mortality. The mouse model, in particular, does not represent the human condition. We
urge caution in applying findings in murine models to septic patients, both with regard
to our understanding of pathophysiology and the failure to translate preclinical efficacy
into successful clinical trials.
Keywords: Faecal peritonitis; Metabolism; Oxygen consumption; Haemodynamics2013 Zolfaghari et al.; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
ttribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any
edium, provided the original work is properly cited.
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Severe sepsis is the exaggerated host inflammatory response to an infectious insult
leading to multiple organ failure (MOF) and, in many cases, death [1]. The underlying
pathophysiology remains poorly understood, and targeted treatments that improve out-
comes remain elusive. Rodent models are routinely used to investigate both patho-
physiological mechanisms and novel therapeutic strategies. This is facilitated by rapid
breeding, ease of care, relatively low costs and powerful genetic technology [2]. A
PubMed search using the words ‘endotoxin’ or ‘sepsis’ for ‘mouse’ and ‘rat’ yielded
10,500 and 5,100 citations, respectively. However, numerous positive therapeutic inter-
vention studies in such laboratory models have failed to translate into clinical benefit in
subsequent human trials. This has resulted in much closer scrutiny of these models
and their relevance to patients [3,4]. Many are poorly representative of the human con-
dition in terms of the type of septic insult (e.g. injection of endotoxin), study duration
(hours rather than days), lack of any resuscitation (such as fluid), and the timing of pu-
tative therapies (often given at or preceding the insult rather than after establishment
of organ dysfunction, as would be the case in patients). The physiological, immuno-
logical and biochemical phenotype of these models, and temporal changes thereof, are
also largely unknown.
Over the last decade, we have attempted to create well-characterized rat and mouse
models that are more representative of the human condition in terms of type (faecal
peritonitis) and duration of insult (≥24 h), with fluid resuscitation to avoid tissue hypo-
perfusion related to untreated hypovolaemia [5-7]. Here, we report a detailed assess-
ment of the cardiovascular, metabolic and biochemical phenotypes in long-term rat and
mouse sepsis models with similar mortality. Concurrent with a recent publication report-
ing non-concordance in leukocyte transcriptional changes between human and murine
systemic inflammatory states including sepsis [8], we describe an early severity-related
hypometabolic and hypodynamic state in our mouse model that further calls into question
its validity as a paradigm for human sepsis.
Materials and methods
All experiments were performed in accordance with the UK Animals (Scientific
Procedures) Act of 1986 and approval from the University College London Ethics Com-
mittee. All animals were housed under standard conditions with water and chow diet ad
libitum. Operative procedures and echocardiography were performed under general an-
aesthesia while the animals were breathing spontaneously through a facemask entrained
with a mixture of room air and isoflurane. Animals were externally warmed during an-
aesthesia to maintain body temperature between 36°C and 38°C. In mice, the depth of
anaesthesia was titrated at each time point using the loss of reflex withdrawal to pain as
the end point to minimize the cardiovascular effects of isoflurane. In rats, a fixed per-
centage (2.5% during surgical procedures and 1.5% for induction of sepsis and echocar-
diography) of isoflurane was used throughout. Room temperature was maintained at a
constant 21°C.
Rat model
Wistar rats (male, with approximately 300 g body weight, 12 to 14 weeks old) were
anaesthetized and placed in a supine position. Following skin preparation, the left common
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ing with 0.96-mm outside diameter (Biocorp Ltd, Huntingdale, Australia). These were tun-
nelled subcutaneously to the back of the neck and attached to a swivel/tether system
(InsTech, Plymouth Meeting, PA, USA). The neck incision was closed, and subcutaneous
(s/c) buprenorphine (0.05 mg/kg) (Vetergesic, Reckitt Benckiser, York, UK) was adminis-
tered for pain relief prior to cessation of anaesthesia. The tether system allowed free move-
ment around the cage with ad libitum access to food and water. The arterial line was
connected to a pressure transducer (Powerlab, AD Instruments, Chalgrove, Oxon, UK) for
continuous measurement of mean arterial pressure recorded using a 16-channel Powerlab
system and Chart 5.0 acquisition software (AD Instruments, Chalgrove, Oxon, UK).
Twenty-four hours after line insertion, sepsis was induced with an intraperitoneal in-
jection of faecal slurry (3 ml/kg body weight) administered through a 19G needle
inserted into the right lower quadrant of the abdomen with care taken to avoid bowel
perforation. Sham animals (control group) received an equivalent volume of 0.9% saline.
Standardized human slurry (pooled stool from three healthy, non-vegetarian donors)
was kindly donated by the Department of Anesthesiology and Intensive Care at Friedrich
Schiller University, Jena, Germany [9]. A continuous infusion of 6% hydroxyethyl starch
130/0.4 (Volulyte, Fresenius Kabi, Bad Homburg, Germany) and glucose (1:1) at 10 ml/kg/h
was administered through the internal jugular line commencing 2 h post-induction of
sepsis. For survival studies exceeding 24 h, the rate was halved at 24-h intervals. These
studies were performed prior to knowledge of the negative outcomes seen with
starch-based intravenous fluids [10,11]. Pilot studies revealed significant hypogly-
caemia if glucose was not administered.
Mouse model
C57 black mice (male, 25 to 35 g body weight, 18 to 30 weeks old) were initially made
septic using the same technique as for the rats, with prior carotid and internal jugular
cannulation and connection to a tether system. However, this method induced signifi-
cant morbidity and mortality in the sham-operated group so was abandoned in favour
of a simplified model without invasive arterial and venous cannulae. Sepsis was induced
by injection of faecal slurry (20 ml/kg body weight) into the peritoneal cavity through a
small (4 mm) transverse abdominal skin incision. Sham animals received the same inci-
sion and were injected with an equivalent volume of 0.9% saline. Faecal slurry was
made fresh each day by diluting caecal content of rats (1:7 dilution with 0.9% saline).
Mice were given 10 ml/kg of 0.9% saline s/c at the end of the procedure and received
further s/c boluses of 50 ml/kg of pre-warmed 5% glucose/0.81% saline at 6 and 12 h
thereafter for both fluid resuscitation and prevention of hypoglycaemia.
Basic measurements and biochemistry
A clinical scoring system (Table 1) was used to record the severity of sepsis for each
animal. This scoring system was previously validated in rats [5]. Clinical scores of 0 to
3 implied mild sepsis and ≥4 severe sepsis. Rectal temperature was measured at 0-, 6-,
18- and 24-h time points. At 24 h post-insult, mice were rapidly anaesthetized and the
blood obtained by cardiac puncture as a terminal event. In rats, the blood was drawn
from the arterial line without using anaesthesia. Samples were analyzed for blood gases
and biochemistry.




Conjunctival injection/mucky eyes 0-1
Piloerection (rats only) 0-1
Lack of movement 0-2
Lack of alertness 0-2
Scoring denotes absence (0), presence (1) or marked presence (2). Total score of 0 to 3 denotes mild sepsis and ≥4
severe sepsis.
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Following induction of sepsis and in-time-matched sham-operated controls (23 rats
and 19 mice in total), whole body metabolic rate was measured for 24 h in individual
metabolic chambers (Oxymax System, Columbus Instruments, Columbus, OH, USA).
Gas samples from each box were sampled for 90 s at 8-min intervals. Oxygen con-
sumption (VO2) and CO2 production (VCO2) were calculated using standard formulae.
The respiratory exchange ratio (RER) was calculated as the ratio of VCO2 to VO2.
Values near 1 indicate a predominance of carbohydrate metabolism while values ap-
proaching 0.7 indicate fatty acid oxidation [12].
Animals were acclimatized in their metabolic cages for at least 3 h prior to induction
of sepsis. All experiments were started at the same time of day to avoid bias due to di-
urnal variation in metabolic rate. Mice were recovered for 1 h in a warm chamber fol-
lowing general anaesthesia prior to returning to their cages.
In separate studies, mice were removed from their metabolic cages at 10 and
24 h and then re-warmed in a heating chamber to 37°C (rectal temperature) over
1.5 h. Echocardiography was performed under a brief period of isoflurane anaesthesia
before and immediately after re-warming, and then the mice were returned promptly to
their metabolic cages where oxygen consumption recordings were resumed within 1 to
2 min.
Cardiac output measurement
Echocardiography was performed at 0, 6 and 24 h in sham and septic animals using a
14-MHz probe connected to a Vivid 7 Dimension echocardiography machine (GE
Healthcare, Chalfont St. Giles, Bucks, UK). The aortic blood flow velocity was mea-
sured in the proximal ascending aorta immediately before the bifurcation of the right
carotid artery using pulse-wave Doppler. Aortic diameters in rats and mice of this age
are, respectively, 2.6 mm [13] and 1.35 mm (S Hollenberg, personal communication).
Stroke volume was calculated by multiplying the velocity time integral (VTI) from six
consecutive cycles (equivalent to one respiratory cycle) by the aortic cross-sectional
area. The average peak-to-peak distance and maximum velocity over the six consecu-
tive systolic cycles were used to measure heart rate and peak velocity, with the latter
being a marker of left ventricular contractility [14]. Cardiac output was calculated as
the product of stroke volume and heart rate.
Survival studies
In separate studies, animals were followed for up to 72 h to assess survival.
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PASW Version 18.0 (SPSS Inc., Chicago, IL, USA) was used to carry out statistical
tests. All variables were tested for normality of distribution using the Kolmogorov-
Smirnov test. All parametric data were compared using Student’s t test or analysis of
variance (one-way or two-way with repeated measures). Statistical significance level
was set at p < 0.05. Tukey’s HSD and Dunnett’s post hoc tests were used to ascertain
the significance between groups.
Results
Survival studies were carried out in 10 sham and 30 septic mice, and 5 sham and 12
septic rats. Similar survival curves were observed in both rodent models; most of the deaths
had occurred by 48 h with an approximately 75% mortality at 72 h (Figure 1A,B). Animals
surviving to this point showed signs of clinical recovery. Of the septic animals surviving to
24 h, 38% of the mice were scored as mild and 62% as severe at this time point, while 33%
of the rats were scored mild and 66% severe. The clinical score at 6 and 24 h in the mice
and at 24 h in the rats is related to subsequent mortality (Figure 1C,D).
Metabolic measurements in mice were made over 24 h in six controls, six with mild
sepsis and seven with severe sepsis. Sham-operated control mice remained normother-
mic and showed normal diurnal rhythmicity in VO2, both consistent with an increase
in nocturnal activity (Figure 2A,C). By contrast, all septic mice became hypothermic
with a significant severity-related drop in temperature at 6 h (p = 0.001 two-way
ANOVA). However, while core temperature fell by 1.5°C in mildly septic mice, severely





















































































Figure 1 Seventy-two hour survival curves in the mouse (A) and rat (B) models of sepsis. Clinical
severity was scored for each animal at 6 and 24 h using a previously published scoring system (5). The
average score (± SEM) for mildly (C) and severely septic (D) animals is shown. Sham mice scored 0 at both
time points. *p < 0.01 one-way ANOVA and §p < 0.01 (ANOVA), comparing mild and severe to the sham











































































Sham Mild septic Severe septic
Figure 2 Core temperature (A,B), VO2 (C,D) and RER (E,F) of sham, mildly and severely septic mice
and rats. Results are mean ± SEM. *p < 0.01 two-way ANOVA.
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dependent reductions in VO2 and VCO2 (Figure 2C). This was associated with a
complete absence of variability (diurnal and movement/feeding related) in the individ-
ual VO2 traces. Compared to baseline values, VO2 in the severely septic mice fell by
38% ± 9% within 2 h, by 63% ± 8% within 6 h and as high as 80% ± 3% reduction at
22 h. In contrast, VO2 in mildly affected mice fell by 30% ± 7% at 6 h. Whereas no
recovery was seen in severely septic animals, core temperature and metabolic rate re-
covered to normal values in the mildly septic mice by 18 h, in line with their clinical
improvement.
To assess the effects of hypothermia, separate re-warming studies showed partial res-
toration of haemodynamics at 10 h and complete restoration at 24 h; however, oxygen
consumption only increased from 32% to 40% of the baseline values to 41% to 52% and
quickly fell thereafter (Table 2, Figure 3).
Table 2 Temperature, metabolic and echocardiography data in severely septic mice
Baseline 10-h 24-h
Pre-rewarming Post-rewarming Pre-rewarming Post-rewarming
Temperature (°C) 36.1 ± 0.2 30.0 ± 1.5* 36.3 ± 0.6** 28.8 ± 2.1* 36.6 ± 1.7
VO2 (ml/kg/h) 2,288 ± 181 925 ± 131* 1,190 ± 131** 730 ± 90* 941 ± 178
Peak velocity (m/s) 1.06 ± 0.06 0.46 ± 0.08* 0.80 ± 0.10** 0.66 ± 0.07* 1.14 ± 0.13
Heart rate (beats/min) 509 ± 31 452 ± 23 601 ± 45** 435 ± 6 614 ± 47
Stroke volume (μl) 60 ± 3 21 ± 3* 32 ± 6** 36 ± 4* 52 ± 11
Data were taken from severely septic mice at baseline (0 h) and before and after rewarming at 10 h (6 mice) and 24 h (3 mice).
Rewarming took place over 1.5 h. Mice were only anaesthetized for the period of echocardiography. Values denote mean ±
standard deviation. *p< 0.05 paired t test comparing the values to corresponding baseline (0 h) values. **p < 0.05 paired t test
comparing post-warming values to their corresponding pre-warming value.
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tained their core temperature (Figure 2B). While a transient 15% ± 2% fall in VO2
(p = 0.001) was observed in the first hour following slurry administration in both mildly
(n = 6) and severely affected (n = 7) rats, this promptly recovered to sham values (Figure 2D).
Despite maintaining their core temperature, the severely septic rats showed a progressive
decline in VO2 from 18 h onwards, in tandem with their clinical deterioration. Three of the
severely affected rats died by 24 h, whereas all the mildly septic rats survived the 24 h dur-
ation of the study.
The RER of sham mice exceeded 0.9 from 8 h onwards, whereas in both mild and se-
vere sepsis this fell promptly to approximately 0.75 (Figure 2E). Food intake was mark-















































s/c fluids s/c fluids 
Figure 3 Change in metabolic rate on rewarming. VO2 and core temperature of mice with severe sepsis
undergoing two episodes of rewarming over a 1.5 h time period (marked by the dashed lines). Mice were
treated with s/c fluid boluses at 6- and 18-h time points (error bars denote standard deviation). *p < 0.05.
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fected septic subsets (Figure 2F).
Echocardiography was performed in 10 sham and 30 septic mice under isoflurane an-
aesthesia. Baseline echocardiographic variables were similar in both sham and septic
mouse groups (Figure 4). However, at 6 h, all measured variables were significantly
lower in the septic mice (p < 0.05). By 24 h these had recovered in the mildly septic
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Figure 4 Echocardiography results at baseline, 6 and 24 h after induction of sepsis in mice and rats.
*p < 0.05 significance severely septic group against other groups; ** p < 0.05 significance both mildly and
severely septic against sham; § p < 0.05 significant difference between all groups (all two-way ANOVA).
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the mice, peak velocity and other haemodynamic variables were similar in septic and
sham animals at 6 h and unchanged from baseline values in naïve rats. However, these
measures significantly deteriorated by 24 h in the severely septic animals (Figure 4).
Blood sampling in mice at 24 h revealed no hypoxaemia but a marked mixed meta-
bolic and respiratory acidosis in the severely septic mice (Table 3). Acid–base balance
and arterial partial pressure of oxygen were unaffected in the rats, even in the severely
septic group where mild hypocapnia was observed. However, both species became
hyperlactataemic. Despite the aggressive fluid resuscitation, both septic mice and se-
verely septic rats showed significant haemoconcentration. Due to administration of glu-
cose, blood sugar levels were well maintained in both species with no recorded episodes
of hypoglycaemia.
Discussion
The phenotypic differences between septic rodents and humans are poorly character-
ized. In this study we describe profound differences in metabolic and cardiovascular
changes in severe, long-term models of rat and murine sepsis. Although the origin of
the faecal slurry and the route of fluid administration differed, the age of the animals
(approximating to juvenile/early adulthood) and laboratory conditions were similar,
as were the time to death and the overall 72-h mortality rate (approximately 75%)
of both models.
The major finding of our study was the marked and rapid decrease in metabolism in
septic mice. While significant hypothermia is recognized following endotoxin or bacter-
ial insults in mice [15-20], the 80% reduction in metabolic rate has not, to our know-
ledge, been previously reported. There was a corresponding change in cardiovascular
phenotype with rapid severity-dependent reductions in heart rate and stroke volume.
Despite an almost twofold rise in the cardiac output (and hence oxygen delivery) fol-
lowing re-warming of the septic mice, there was only a very modest rise in VO2. This
implies that the metabolic suppression in the septic mice is independent of the core
temperature or oxygen delivery. By contrast, the septic rats did not exhibit early falls inTable 3 Blood gas results (mean ± SEM) at 24 h in sham, mildly septic (rats only) and
severely septic mice and rats
Mouse Rat
Sham Severe septic Sham Mild septic Severe septic
pH 7.33 ± 0.03 6.96 ± 0.12* 7.45 ± 0.02 7.44 ± 0.02 7.52 ± 0.04
PCO2 (kPa) 4.29 ± 0.29 8.46 ± 4.14* 4.3 ± 0.1 4.4 ± 0.1 3.2 ± 0.2*
PO2 (kPa) 13.4 ± 4.2 12.2 ± 4.3 13.8 ± 0.2 14.2 ± 0.1 17.6 ± 2.6
HCO3
− (mmol/l) 17.7 ± 0.5 10.9 ± 1.7* 23.9 ± 1.7 23.7 ± 0.8 25.0 ± 1.6
Cl− (mmol/l) 122 ± 5 122 ± 2 106 ± 2 106 ± 2 104 ± 2
BE (mmol/l) −8.5 ± 0.7 −18.0 ± 3.2* −1.3 ± 1.9 −1.3 ± 0.9 −3.0 ± 2.6
Lactate (mmol/l) 2.4 ± 0.9 5.0 ± 1.2* 0.8 ± 0.1 1.7 ± 0.3 2.6 ± 0.4*
Glucose (mmol/l) 11.7 ± 4.0 14.9 ± 2.4 7.0 ± 0.7 6.4 ± 0.8 5.4 ± 0.7
Hb (g/dl) 13.2 ± 0.2 15.1 ± 1.6* 12.2 ± 0.5 12.0 ± 1.0 13.9 ± 0.9
MAP at 24 h (mmHg) - - 118 ± 2 100 ± 10 95 ± 10
MAP, mean arterial pressure; Hb, haemoglobin concentration; BE, base excess. *p < 0.05 comparing severely septic to
sham and mildly septic animals.
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seen over the 4 to 6-h period pre-mortem.
In humans the early response to low-dose endotoxin injection in volunteers is a hy-
permetabolic response with 89% and 46% rises in oxygen delivery and consumption, re-
spectively by 3 h [21]. However, in septic patients, the increased metabolic response is
progressively blunted with increasing severity such that the resting energy expenditure
in was equivalent to normal healthy values [22]. Only in the recovery phase was a hy-
permetabolic response (up to 60% increase) noted [22,23]. By contrast, and as we found
with the septic rats, VO2 fell in critically ill patients during their dying process [24].
The reduced respiratory exchange ratio in the septic mice implies predominance of
fatty acid oxidation as compared to the sham animals that use carbohydrate as their
main energy source [12], even though high lactate levels result in an increase in VCO2
and RER [25]. This switch in fuel utilization is often seen in sick animals and during
starvation and has also been reported in septic mice [20]. Studies in healthy mice
starved for 20 h confirmed a similar fall in RER to 0.73 with a 25% fall in VO2 that re-
versed quickly on re-provision of food (data not shown). Notably, temperature did not
change in this starvation model. Furthermore, as there was only an 11% variation in the
VO2 observed with sleep-wake cycles in naïve mice (Additional file 1: Figure S1), de-
creased activity in the septic mice is likely to make only a relatively minor contribution
to the profound reduction in metabolic rate observed.
The different metabolic responses within the two rodent species may reflect the pres-
ence of intact hibernatory pathways in mice. Metabolic suppression has been described
in various organisms including mice under unfavourable situations such as cold, food
or fluid deprivation, and hypoxia [26]. This strategy of ‘cross-tolerance’ results in a bal-
anced reduction in energy production and utilization [27], enabling continuation of
life-dependent processes such as membrane pumps at the expense of other energy-
dependent functions such as protein synthesis [28,29]. Metabolic suppression may be
also triggered by a reduction in energy supply [30,31]. Hibernation has been described
in the septic mouse heart [32] and suggested in human critical illness [33,34]. Meta-
bolic suppression may be an adaptive response in severe sepsis in order to conserve
energy [34] and, perhaps, limit reactive species production.
Mice have a very high metabolic rate (VO2 of 60 to 80 ml/kg/min compared with 3
to 4 ml/kg/min in humans), largely due to non-shivering thermogenesis to maintain
body temperature [35]. It is difficult to assess the contribution of loss of non-shivering
thermogenesis to the reduction in VO2 and core temperature observed in our mouse
model. While it is tempting to speculate that this may occur, our study was designed to
measure total oxygen consumption and could not distinguish between coupled and
uncoupled respiration. Non-shivering thermogenesis is mediated by mitochondrial un-
coupling proteins (principally UCP-1 in brown fat) as a result of beta-adrenergic stimu-
lation [36]. Interestingly however, both catecholamine levels and UCP protein levels
rise in sepsis [37-40]. The significance of upregulation of the uncoupling proteins UCP-
2 and UCP-3 in sepsis is still unclear; however, there is no evidence that these influence
thermoregulation [39].
Our protocol utilized fluid resuscitation, equivalent to 150 ml/kg s/c for mice and
220 ml/kg i/v in rats over the first 24 h. Notwithstanding these large volumes that are
considerably higher than those reported in the literature [4], haemoglobin concentrations
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haemoconcentration due to increased capillary leak. While hypovolaemia may have con-
tributed in part to the reduced cardiac output seen at 6 and 24 h in mice and at 24 h in
rats, the lack of tachycardia does imply that intrinsic sepsis-related myocardial depression
and/or hypothermia (in the mice) also play a significant role. Transient re-warming of the
mice to 37°C increased cardiac output (fully at 24 h) but only had a partial effect on global
oxygen consumption. This was contrary to the previous observations by Rudaya et al. [18]
who noted that thermoregulatory responses in LPS-treated mice were dependent on the
ambient temperature. Our data imply that metabolic shutdown is an important phenotypic
response to sepsis in mice.
Severity as measured by the clinical scoring system was predictive of mortality. While
we have previously evaluated and utilized this score in rat models of sepsis [5,41], this
is the first description of its use in a murine model, where mortality and serum bio-
chemical markers of organ failure correlated with clinical severity (data not shown). All
mice that scored ≥4 subsequently died, while those with scores ≤3 survived.
The severely septic mice developed a mixed respiratory and metabolic acidosis with
hyperlactataemia. Hyperchloraemia also contributes in part to the metabolic acidosis;
as this was also observed in the sham mice, it is likely related to the chloride-rich fluid
used for fluid resuscitation, which may have been avoided had a balanced crystalloid so-
lution been used instead. Nevertheless, acid–base balance was relatively unaffected in
the severely septic rats with only mild hypocapnia and hyperlactataemia.
Limitations of our study include an inability to directly reproduce the study design in
both rodent species. We did initially use a tether system and vascular instrumentation
under anaesthesia to enable continuous intravenous fluid administration in mice, but this
proved too stressful and injurious, even for non-septic controls, and had to be abandoned.
Thus, the mice did not receive any surgical trauma and their fluid regimens were, by neces-
sity, different. Importantly, however, the 72-h mortality rates were identical so we opted
not to use a model involving repeated subcutaneous fluid injections in the rats. We also
did not use antibiotics as the intention was to compare haemodynamic and metabolic re-
sponses between species with an insult of comparable mortality.Conclusions
We demonstrate markedly differing metabolic and cardiovascular profiles in long-term
rat and mouse models of bacterial sepsis with similar mortality. The mouse model, in
particular, exhibits early severity-dependent metabolic down-regulation soon after the
initiation of sepsis. Other models of sepsis involving different insults, treatment regi-
mens, laboratory conditions (e.g. ambient temperatures), ages and gender should also
be examined to assess reproducibility of findings. In the meantime, we suggest that cau-
tion be applied in extrapolating findings in murine models to septic patients, both with
regard to our understanding of pathophysiology and the failure to translate preclinical
efficacy into successful clinical trials.
Additional file
Additional file 1: Figure S1. Averaged trace of VO2 of two naïve mice and four naïve rats over 48 to 72 h with
12-h dark periods marked (grey bar at top). Error bars depict standard deviation.
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